Improved Drug-target Interaction Prediction with Intermolecular Graph
  Transformer
  The identification of active binding drugs for target proteins (termed as
drug-target interaction prediction) is the key challenge in virtual screening,
which plays an essential role in drug discovery. Although recent deep
learning-based approaches achieved better performance than molecular docking,
existing models often neglect certain aspects of the intermolecular
information, hindering the performance of prediction. We recognize this problem
and propose a novel approach named Intermolecular Graph Transformer (IGT) that
employs a dedicated attention mechanism to model intermolecular information
with a three-way Transformer-based architecture. IGT outperforms
state-of-the-art approaches by 9.1% and 20.5% over the second best for binding
activity and binding pose prediction respectively, and shows superior
generalization ability to unseen receptor proteins. Furthermore, IGT exhibits
promising drug screening ability against SARS-CoV-2 by identifying 83.1% active
drugs that have been validated by wet-lab experiments with near-native
predicted binding poses.
